Amgen IncNASDAQ:AMGN
- LAST PRICE269.9800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots262.3000/ 1
- Ask / Lots271.7600/ 1
- Open / Previous Close0.0000 / 269.9800
- Day Range---
- 52 Week Range
- Volume6
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AMGN |
|---|---|---|
| 09:32 ET | 26637 | 267.49 |
| 09:34 ET | 6996 | 269.7 |
| 09:36 ET | 3723 | 269.03 |
| 09:38 ET | 6523 | 269.4 |
| 09:39 ET | 4747 | 269.73 |
| 09:41 ET | 1232 | 269.94 |
| 09:43 ET | 4599 | 270.37 |
| 09:45 ET | 7135 | 270.56 |
| 09:48 ET | 2805 | 269.56 |
| 09:50 ET | 2145 | 269.355 |
| 09:52 ET | 1678 | 269.88 |
| 09:54 ET | 3447 | 269.6 |
| 09:56 ET | 1121 | 269.6 |
| 09:57 ET | 2759 | 269.2364 |
| 09:59 ET | 1742 | 269.38 |
| 10:01 ET | 1132 | 269.92 |
| 10:03 ET | 2066 | 270.38 |
| 10:06 ET | 1877 | 270.495 |
| 10:08 ET | 2379 | 271.07 |
| 10:10 ET | 2000 | 270.755 |
| 10:12 ET | 2614 | 271.33 |
| 10:14 ET | 3264 | 271.52 |
| 10:15 ET | 3482 | 271.435 |
| 10:17 ET | 7298 | 271.03 |
| 10:19 ET | 2040 | 270.89 |
| 10:21 ET | 700 | 270.864 |
| 10:24 ET | 2177 | 270.54 |
| 10:26 ET | 2049 | 270.5 |
| 10:28 ET | 800 | 270.545 |
| 10:30 ET | 4545 | 270.09 |
| 10:32 ET | 1900 | 270.59 |
| 10:33 ET | 1700 | 270.48 |
| 10:35 ET | 500 | 270.54 |
| 10:37 ET | 2450 | 270.71 |
| 10:39 ET | 1401 | 270.71 |
| 10:42 ET | 1622 | 270.77 |
| 10:44 ET | 965 | 270.38 |
| 10:46 ET | 500 | 270.04 |
| 10:48 ET | 3000 | 269.735 |
| 10:50 ET | 1538 | 270.1 |
| 10:51 ET | 4829 | 270.32 |
| 10:53 ET | 2511 | 270.34 |
| 10:55 ET | 2400 | 269.95 |
| 10:57 ET | 2254 | 269.56 |
| 11:00 ET | 2229 | 269.46 |
| 11:02 ET | 900 | 269.62 |
| 11:04 ET | 3490 | 270.2 |
| 11:06 ET | 4200 | 269.73 |
| 11:08 ET | 2100 | 269.86 |
| 11:09 ET | 2687 | 269.85 |
| 11:11 ET | 2346 | 269.8 |
| 11:13 ET | 1714 | 269.69 |
| 11:15 ET | 1700 | 269.75 |
| 11:18 ET | 3567 | 269.81 |
| 11:20 ET | 1975 | 269.91 |
| 11:22 ET | 1000 | 269.62 |
| 11:24 ET | 600 | 269.56 |
| 11:26 ET | 600 | 269.66 |
| 11:27 ET | 1114 | 269.89 |
| 11:29 ET | 1200 | 269.63 |
| 11:31 ET | 1531 | 269.6 |
| 11:33 ET | 2100 | 269.7 |
| 11:36 ET | 1000 | 269.81 |
| 11:38 ET | 1706 | 269.78 |
| 11:40 ET | 2032 | 269.92 |
| 11:42 ET | 2128 | 269.83 |
| 11:44 ET | 2875 | 269.97 |
| 11:45 ET | 1854 | 270.02 |
| 11:47 ET | 1950 | 270.21 |
| 11:49 ET | 2204 | 270.15 |
| 11:51 ET | 736 | 270.015 |
| 11:54 ET | 1869 | 269.8401 |
| 11:56 ET | 1706 | 270.1 |
| 11:58 ET | 800 | 269.75 |
| 12:00 ET | 2435 | 269.71 |
| 12:02 ET | 333 | 269.82 |
| 12:03 ET | 1954 | 269.77 |
| 12:05 ET | 1495 | 269.78 |
| 12:07 ET | 500 | 269.65 |
| 12:09 ET | 1710 | 269.76 |
| 12:12 ET | 7239 | 270.37 |
| 12:14 ET | 3519 | 270.05 |
| 12:16 ET | 877 | 269.97 |
| 12:18 ET | 6781 | 270.07 |
| 12:20 ET | 1503 | 270 |
| 12:21 ET | 10137 | 270.19 |
| 12:23 ET | 800 | 270.06 |
| 12:25 ET | 931 | 269.865 |
| 12:27 ET | 1513 | 269.55 |
| 12:30 ET | 2289 | 269.795 |
| 12:32 ET | 1300 | 269.67 |
| 12:34 ET | 546 | 269.61 |
| 12:36 ET | 5738 | 269.81 |
| 12:38 ET | 3274 | 269.84 |
| 12:39 ET | 1100 | 269.81 |
| 12:41 ET | 7958 | 269.84 |
| 12:43 ET | 1286 | 269.6 |
| 12:45 ET | 520 | 269.89 |
| 12:48 ET | 2240 | 269.73 |
| 12:50 ET | 1400 | 269.78 |
| 12:52 ET | 2903 | 269.97 |
| 12:54 ET | 1022 | 269.905 |
| 12:56 ET | 1212 | 269.7894 |
| 12:57 ET | 3912 | 270.06 |
| 12:59 ET | 1000 | 269.995 |
| 01:01 ET | 1000 | 270.04 |
| 01:03 ET | 1700 | 270.09 |
| 01:06 ET | 12903 | 270 |
| 01:08 ET | 2529 | 269.98 |
| 01:10 ET | 4327 | 269.8 |
| 01:12 ET | 2657 | 269.78 |
| 01:14 ET | 2777 | 269.86 |
| 01:15 ET | 1246 | 269.7862 |
| 01:17 ET | 6038 | 269.96 |
| 01:19 ET | 1413 | 270.16 |
| 01:21 ET | 4115 | 270.11 |
| 01:24 ET | 3465 | 270.235 |
| 01:26 ET | 7396 | 270.12 |
| 01:28 ET | 5939 | 270.17 |
| 01:30 ET | 200 | 270.19 |
| 01:32 ET | 1600 | 270.11 |
| 01:33 ET | 250 | 270.17 |
| 01:35 ET | 1327 | 270.2 |
| 01:37 ET | 600 | 270.39 |
| 01:39 ET | 2546 | 270.41 |
| 01:42 ET | 2768 | 270.39 |
| 01:44 ET | 2866 | 270.4 |
| 01:46 ET | 816 | 270.389 |
| 01:48 ET | 4037 | 270.25 |
| 01:50 ET | 1762 | 270.35 |
| 01:51 ET | 2692 | 270.39 |
| 01:53 ET | 716 | 270.44 |
| 01:55 ET | 5610 | 270.78 |
| 01:57 ET | 5800 | 270.82 |
| 02:00 ET | 14451 | 270.8 |
| 02:02 ET | 9454 | 270.54 |
| 02:04 ET | 6373 | 270.935 |
| 02:06 ET | 10360 | 270.955 |
| 02:08 ET | 2763 | 270.82 |
| 02:09 ET | 9705 | 270.75 |
| 02:11 ET | 6508 | 270.95 |
| 02:13 ET | 3000 | 271.09 |
| 02:15 ET | 3096 | 271.1 |
| 02:18 ET | 4812 | 270.99 |
| 02:20 ET | 2420 | 270.985 |
| 02:22 ET | 4603 | 271 |
| 02:24 ET | 3727 | 270.93 |
| 02:26 ET | 967 | 270.77 |
| 02:27 ET | 3662 | 271.04 |
| 02:29 ET | 4261 | 270.895 |
| 02:31 ET | 637 | 270.91 |
| 02:33 ET | 2521 | 270.9 |
| 02:36 ET | 1614 | 270.8979 |
| 02:38 ET | 4619 | 271.27 |
| 02:40 ET | 3275 | 271.13 |
| 02:42 ET | 2517 | 271.12 |
| 02:44 ET | 2300 | 271.215 |
| 02:45 ET | 2780 | 271.18 |
| 02:47 ET | 1404 | 271.19 |
| 02:49 ET | 3485 | 271.03 |
| 02:51 ET | 2600 | 270.88 |
| 02:54 ET | 8998 | 270.96 |
| 02:56 ET | 2639 | 270.9425 |
| 02:58 ET | 7543 | 271.01 |
| 03:00 ET | 1608 | 271.12 |
| 03:02 ET | 16490 | 271.24 |
| 03:03 ET | 4830 | 271.1875 |
| 03:05 ET | 1119 | 271.155 |
| 03:07 ET | 3883 | 271.1 |
| 03:09 ET | 3828 | 271.03 |
| 03:12 ET | 2116 | 270.985 |
| 03:14 ET | 5467 | 271.03 |
| 03:16 ET | 3004 | 271.11 |
| 03:18 ET | 3724 | 271 |
| 03:20 ET | 4110 | 271.092 |
| 03:21 ET | 5235 | 271 |
| 03:23 ET | 7846 | 271 |
| 03:25 ET | 3487 | 271.015 |
| 03:27 ET | 2264 | 271.03 |
| 03:30 ET | 1543 | 271 |
| 03:32 ET | 4381 | 271.04 |
| 03:34 ET | 6999 | 270.98 |
| 03:36 ET | 4170 | 271.1 |
| 03:38 ET | 4690 | 271.04 |
| 03:39 ET | 5693 | 271.02 |
| 03:41 ET | 18110 | 271.0456 |
| 03:43 ET | 11336 | 270.99 |
| 03:45 ET | 21565 | 271.05 |
| 03:48 ET | 10742 | 270.97 |
| 03:50 ET | 4030 | 270.91 |
| 03:52 ET | 7912 | 270.4 |
| 03:54 ET | 12204 | 270.45 |
| 03:56 ET | 29917 | 270.25 |
| 03:57 ET | 17584 | 270.005 |
| 03:59 ET | 40542 | 269.98 |
Apr 26, 2024
DJ Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza, from 9:22AM ET on Friday Apr 26, 2024 by Dow Jones
9:22AM ET on Friday Apr 26, 2024 by Dow JonesAMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY, from 9:00AM ET on Friday Apr 26, 2024 by Dow Jones
9:00AM ET on Friday Apr 26, 2024 by Dow Jones
Apr 18, 2024
DJ Amgen Is Maintained at Neutral by UBS, from 7:41AM ET on Thursday Apr 18, 2024 by Dow Jones
7:41AM ET on Thursday Apr 18, 2024 by Dow Jones
Apr 17, 2024
DJ Amgen Is Maintained at Buy by TD Cowen, from 6:12AM ET on Wednesday Apr 17, 2024 by Dow Jones
6:12AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 16, 2024
AMGEN TO PRESENT TEZSPIRE(R) PHASE 2A COPD DATA AT ATS 2024, from 5:26PM ET on Tuesday Apr 16, 2024 by Dow Jones
5:26PM ET on Tuesday Apr 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amgen Inc | 144.8B | 21.6x | -0.22% |
Gilead Sciences Inc | 81.6B | 181.9x | +1.53% |
GSK plc | 85.7B | 13.7x | +6.39% |
Bristol-Myers Squibb Co | 90.9B | -14.5x | +4.90% |
Sanofi SA | 123.8B | 25.5x | +4.55% |
HALEON PLC | 38.2B | 30.0x | --- |
Company Information
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and improve people's lives. It operates in human therapeutics segment. The Company’s marketed products portfolio includes Aranesp, ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine), KYPROLIS (carfilzomib), Maridebart cafraglutide, (infliximab-axxq), Evenity, LumaKras, Nplate and XGeva, others.
Contact Information
- Headquarters
- One Amgen Center DriveTHOUSAND OAKS, CA, United States 91320
- Phone
- 805-447-1000
- Fax
- 805-447-1010
Executives
- Chairman of the Board, President, Chief Executive Officer
- Robert Bradway
- Chief Financial Officer, Executive Vice President
- Peter Griffith
- Executive Vice President, Chief Technology Officer
- David Reese
- Executive Vice President, Research and Development, and Chief Scientific Officer
- James Bradner
- Executive Vice President, General Counsel, Secretary
- Jonathan Graham
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $144.8B |
|---|---|
Revenue (TTM) | $28.2B |
Shares Outstanding | 536.4M |
Dividend Yield | 3.33% |
Annual Dividend Rate | 9.0000 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-07-24 |
Beta | 0.60 |
EPS | $12.49 |
Book Value | $11.64 |
P/E Ratio | 21.6x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | 13.4x |
Operating Margin | 28.29% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
